Home › Ovarian Cancer › NCT06800105
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
RecruitingObservational study
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Women * Age \>18 * Presumed ovarian cancer diagnosis (i.e. those being clinically evaluated for suspicion of ovary cancer) * Planned treatment course for ovarian cancer involving cytoreductive surgery followed by chemotherapy * Availability to commit to attending all study visits * Internet access and consistent access to phone/email/text communication Exclusion Criteria: * Pregnancy * Inability to provide voluntary informed consent * Inability to consume the pre-study visit meal/snack and/or the study visit meal due to strict dietary restrictions * Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators * Circumstances and/or medical condition that would limit compliance with study requirements and protocol, as determined by the principal investigators
About the study
Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.
What is being tested
- High fat smoothie (other)
Sponsor: University of Tennessee Graduate School of Medicine · Participants: 10 · Started: Mar 22, 2023
Contact the study team
- Jill M Maples, PhD · Phone: 8653059367
Official record on ClinicalTrials.gov — NCT06800105
Locations in the U.S.
| Tennessee | University of Tennessee Graduate School of Medicine, Knoxville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.